Pseudomonas aeruginosa exoenzymes U and Y induce a transmissible endothelial proteinopathy

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 310, Issue 4, 2016, Pages L337-L353

  Morrow, K Adam ^a,b   Ochoa, Cristhiaan D ^c   Balczon, Ron ^a,b   Zhou, Chun ^a,b   Cauthen, Laura ^a,b   Alexeyev, Mikhail ^a,b   Schmalzer, Katherine M ^d   Frank, Dara W ^d   Stevens, Troy ^a,b  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Aggregation; Infection; Microtubules; Pneumonia; Proteinopathy

Indexed keywords

BACTERIAL ENZYME; EXOENZYME U; EXOENZYME Y; MATRIGEL; MONOCLONAL ANTIBODY; OLIGOMER; TAU PROTEIN; UNCLASSIFIED DRUG; CYCLIC AMP;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CAPILLARY ENDOTHELIAL CELL; CELL DAMAGE; CONTROLLED STUDY; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; LUNG ENDOTHELIUM; LUNG INJURY; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RAT; SUPERNATANT; TAUOPATHY; TRANSMISSIBLE ENDOTHELIAL PROTEINOPATHY; ANIMAL; ENDOTHELIUM CELL; ENZYMOLOGY; LUNG; METABOLISM; MICROBIOLOGY; MICROVASCULATURE; TRANSMISSION;

ANIMALS; CYCLIC AMP; ENDOTHELIAL CELLS; LUNG; MICROVESSELS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RATS;

EID: 84958559488     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00103.2015     Document Type: Article

References (72)

1. Aguzzi A, Rajendran L. The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron 64: 783-790, 2009.
2. Alexeyev MF, Fayzulin R, Shokolenko IN, Pastukh V. A retro-lentiviral system for doxycycline-inducible gene expression and gene knockdown in cells with limited proliferative capacity. Mol Biol Rep 37: 1987-1991, 2010.
3. Alvarez DF, Gjerde EA, Townsley MI. Role of EETs in regulation of endothelial permeability in rat lung. Am J Physiol Lung Cell Mol Physiol 286: L445-L451, 2004.
4. Balczon R, Overstreet KA, Zinkowski RP, Haynes A, Appel M. The identification, purification, and characterization of a pancreatic beta-cell form of the microtubule adenosine triphosphatase kinesin. Endocrinology 131: 331-336, 1992.
5. Balczon R, Prasain N, Ochoa C, Prater J, Zhu B, Alexeyev M, Sayner S, Frank DW, Stevens T. Pseudomonas aeruginosa exotoxin Y-mediated tau hyperphosphorylation impairs microtubule assembly in pulmonary microvascular endothelial cells. PLos One 8: e74343, 2013.
6. Balin BJ, Little CS, Hammond CJ, Appelt DM, Whittum-Hudson JA, Gerard HC, Hudson AP. Chlamydophila pneumoniae and the etiology of late-onset Alzheimer's disease. J Alzheimers Dis 13: 371-380, 2008.
7. Banaszynski LA, Chen LC, Maynard-Smith LA, Ooi AG, Wandless TJ. A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules. Cell 126: 995-1004, 2006.
8. Bouchard M, Suchowersky O. Tauopathies: one disease or many? Can J Neurol Sci 38: 547-556, 2011.
9. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 82: 239-259, 1991.
10. Clinton LK, Blurton-Jones M, Myczek K, Trojanowski JQ, LaFerla FM. Synergistic interactions between Aβ, τ, and -synuclein: acceleration of neuropathology and cognitive decline. J Neurosci 30: 7281-7289, 2010.
11. Cross DC, Munoz JP, Hernandez P, Maccioni RB. Nuclear and cytoplasmic tau proteins from human nonneuronal cells share common structural and functional features with brain tau. J Cell Biochem 78: 305-317, 2000.
12. Crouch Brewer S, Wunderink RG, Jones CB, Leeper KV Jr. Ventilator- associated pneumonia due to Pseudomonas aeruginosa. Chest 109: 1019-1029, 1996.
13. Crowther RA, Goedert M. Abnormal tau-containing filaments in neurodegenerative diseases. J Struct Biol 130: 271-279, 2000.
14. El-Solh AA, Hattemer A, Hauser AR, Alhajhusain A, Vora H. Clinical outcomes of type III Pseudomonas aeruginosa bacteremia. Crit Care Med 40: 1157-1163, 2012.
15. Emmanouilidou E, Melachroinou K, Roumeliotis T, Garbis SD, Ntzouni M, Margaritis LH, Stefanis L, Vekrellis K. Cell-produced -synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci 30: 6838-6851, 2010.
16. Engel J, Balachandran P. Role of Pseudomonas aeruginosa type III effectors in disease. Curr Opin Microbiol 12: 61-66, 2009.
17. Feltman H, Schulert G, Khan S, Jain M, Peterson L, Hauser AR. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. Microbiology 147: 2659-2669, 2001.
18. Fevrier B, Vilette D, Archer F, Loew D, Faigle W, Vidal M, Laude H, Raposo G. Cells release prions in association with exosomes. Proc Natl Acad Sci USA 101: 9683-9688, 2004.
19. Frost B, Jacks RL, Diamond MI. Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 284: 12845-12852, 2009.
20. Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, Guillozet AL, Lu M, Fu Y, Garcia-Sierra F, LaPointe N, Miller R, Berry RW, Binder LI, Cryns VL. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc Natl Acad Sci USA 100: 10032-10037, 2003.
21. Grimley JS, Chen DA, Banaszynski LA, Wandless TJ. Synthesis and analysis of stabilizing ligands for FKBP-derived destabilizing domains. Bioorg Med Chem Lett 18: 759-761, 2008.
22. Hakki M, Limaye AP, Kim HW, Kirby KA, Corey L, Boeckh M. Invasive Pseudomonas aeruginosa infections: high rate of recurrence and mortality after hematopoietic cell transplantation. Bone Marrow Transplant 39: 687-693, 2007.
23. Hall GF, Saman S. Death or secretion? The demise of a plausible assumption about CSF-τ in Alzheimer disease? Commun Integr Biol 5: 623-626, 2012.
24. Hauser AR. The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat Rev Microbiol 7: 654-665, 2009.
25. Holmes BB, Diamond MI. Prion-like properties of tau protein: the importance of extracellular tau as a therapeutic target. J Biol Chem 289: 19855-19861, 2014.
26. Itzhaki RF, Wozniak MA, Appelt DM, Balin BJ. Infiltration of the brain by pathogens causes Alzheimer's disease. Neurobiol Aging 25: 619-627, 2004.
27. Jeganathan S, Hascher A, Chinnathambi S, Biernat J, Mandelkow EM, Mandelkow E. Proline-directed pseudo-phosphorylation at AT8 and PHF1 epitopes induces a compaction of the paperclip folding of tau and generates a pathological (MC-1) conformation. J Biol Chem 283: 32066- 32076, 2008.
28. Kfoury N, Holmes BB, Jiang H, Holtzman DM, Diamond MI. Transcellular propagation of tau aggregation by fibrillar species. J Biol Chem 287: 19440-19451, 2012.
29. King J, Hamil T, Creighton J, Wu S, Bhat P, McDonald F, Stevens T. Structural and functional characteristics of lung macro- and microvascular endothelial cell phenotypes. Microvasc Res 67: 139-151, 2004.
30. King ME, Gamblin TC, Kuret J, Binder LI. Differential assembly of human tau isoforms in the presence of arachidonic acid. J Neurochem 74: 1749-1757, 2000.
31. Kinoshita J. Pathogens as a cause of Alzheimer's disease. Neurobiol Aging 25: 639-640, 2004.
32. Lange M, Hamahata A, Enkhbaatar P, Esechie A, Connelly R, Nakano Y, Jonkam C, Cox RA, Traber LD, Herndon DN, Traber DL. Assessment of vascular permeability in an ovine model of acute lung injury and pneumonia-induced Pseudomonas aeruginosa sepsis. Crit Care Med 36: 1284-1289, 2008.
33. Lasagna-Reeves CA, Castillo-Carranza DL, Guerrero-Muoz MJ, Jackson GR, Kayed R. Preparation and characterization of neurotoxic tau oligomers. Biochemistry 49: 10039-10041, 2010.
34. Le Berre R, Nguyen S, Nowak E, Kipnis E, Pierre M, Quenee L, Ader F, Lancel S, Courcol R, Guery BP, Faure K, Pyopneumagen G. Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumonia. Crit Care Med 39: 2113-2120, 2011.
35. Liu PV. The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. 3. Identity of the lethal toxins produced in vitro and in vivo. J Infect Dis 116: 481-489, 1966.
36. Lorimer D, Raymond A, Walchli J, Mixon M, Barrow A, Wallace E, Grice R, Burgin A, Stewart L. Gene composer: database software for protein construct design, codon engineering, and gene synthesis. BMC Biotechnol 9: 36, 2009.
37. Micek ST, Lloyd AE, Ritchie DJ, Reichley RM, Fraser VJ, Kollef MH. Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother 49: 1306-1311, 2005.
38. Mietelska-Porowska A, Wasik U, Goras M, Filipek A, Niewiadomska G. Tau protein modifications and interactions: their role in function and dysfunction. Int J Mol Sci 15: 4671-4713, 2014.
39. Morrow KA, Seifert R, Kaever V, Britain AL, Sayner SL, Ochoa CD, Cioffi EA, Frank DW, Rich TC, Stevens T. Heterogeneity of pulmonary endothelial cyclic nucleotide response to Pseudomonas aeruginosa ExoY infection. Am J Physiol Lung Cell Mol Physiol 309: L1199-L1207, 2015.
40. Novak P, Prcina M, Kontsekova E. Tauons and prions: infamous cousins? J Alzheimers Dis 26: 413-430, 2011.
41. Ochoa CD, Alexeyev M, Pastukh V, Balczon R, Stevens T. Pseudomonas aeruginosa exotoxin Y is a promiscuous cyclase that increases endothelial tau phosphorylation and permeability. J Biol Chem 287: 25407-25418, 2012.
42. Ochoa CD, Stevens T, Balczon R. Cold exposure reveals two populations of microtubules in pulmonary endothelia. Am J Physiol Lung Cell Mol Physiol 300: L132-L138, 2011.
43. Ofori-Acquah SF, King J, Voelkel N, Schaphorst KL, Stevens T. Heterogeneity of barrier function in the lung reflects diversity in endothelial cell junctions. Microvasc Res 75: 391-402, 2008.
44. Parker JC, Stevens T, Randall J, Weber DS, King JA. Hydraulic conductance of pulmonary microvascular and macrovascular endothelial cell monolayers. Am J Physiol Lung Cell Mol Physiol 291: L30-L37, 2006.
45. Phillips RM, Six DA, Dennis EA, Ghosh P. In vivo phospholipase activity of the Pseudomonas aeruginosa cytotoxin ExoU and protection of mammalian cells with phospholipase A2 inhibitors. J Biol Chem 278: 41326-41332, 2003.
46. Prasain N, Alexeyev M, Balczon R, Stevens T. Soluble adenylyl cyclasedependent microtubule disassembly reveals a novel mechanism of endothelial cell retraction. Am J Physiol Lung Cell Mol Physiol 297: L73-L83, 2009.
47. Prasain N, Stevens T. The actin cytoskeleton in endothelial cell phenotypes. Microvasc Res 77: 53-63, 2009.
48. Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med 362: 329-344, 2010.
49. Rajendran L, Honsho M, Zahn TR, Keller P, Geiger KD, Verkade P, Simons K. Alzheimer's disease β-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci USA 103: 11172-11177, 2006.
50. Rasool S, Martinez-Coria H, Wu JW, LaFerla F, Glabe CG. Systemic vaccination with anti-oligomeric monoclonal antibodies improves cognitive function by reducing Aβ deposition and tau pathology in 3xTg-AD mice. J Neurochem 126: 473-482, 2013.
51. Saliba AM, de Assis MC, Nishi R, Raymond B, Marques Ede A, Lopes UG, Touqui L, Plotkowski MC. Implications of oxidative stress in the cytotoxicity of Pseudomonas aeruginosa ExoU. Microbes Infect 8: 450- 459, 2006.
52. Saman S, Kim W, Raya M, Visnick Y, Miro S, Saman S, Jackson B, McKee AC, Alvarez VE, Lee NC, Hall GF. Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. J Biol Chem 287: 3842-3849, 2012.
53. Sato H, Frank DW. ExoU is a potent intracellular phospholipase. Mol Microbiol 53: 1279-1290, 2004.
54. Sayner SL, Alexeyev M, Dessauer CW, Stevens T. Soluble adenylyl cyclase reveals the significance of cAMP compartmentation on pulmonary microvascular endothelial cell barrier. Circ Res 98: 675-681, 2006.
55. Sayner SL, Frank DW, King J, Chen H, VandeWaa J, Stevens T. Paradoxical cAMP-induced lung endothelial hyperpermeability revealed by Pseudomonas aeruginosa ExoY. Circ Res 95: 196-203, 2004.
56. Schmalzer KM, Benson MA, Frank DW. Activation of ExoU phospholipase activity requires specific C-terminal regions. J Bacteriol 192: 1801-1812, 2010.
57. Schneider A, Biernat J, von Bergen M, Mandelkow E, Mandelkow EM. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments. Biochemistry 38: 3549-3558, 1999.
58. Segovia JA, Tsai SY, Chang TH, Shil NK, Weintraub ST, Short JD, Bose S. Nedd8 regulates inflammasome-dependent caspase-1 activation. Mol Cell Biol 35: 582-597, 2015.
59. Seifert RH, Wolter S, Reinecke D, Burhenne H, Kaever V, Munder A, Tummler BS, Grundmann M, Kostenis E, Frank DW, Beckert U. Pseudomonas aeruginosa ExoY, a cyclic GMP- and cyclic UMP-generating nucleotidyl cyclase. BMC Pharmacol Toxicol 14 Suppl 1: O1-P80, 2013.
60. Shafikhani SH, Morales C, Engel J. The Pseudomonas aeruginosa type III secreted toxin ExoT is necessary and sufficient to induce apoptosis in epithelial cells. Cell Microbiol 10: 994-1007, 2008.
61. Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg EP. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407: 762-764, 2000.
62. Stevens T, Phan S, Frid MG, Alvarez D, Herzog E, Stenmark KR. Lung vascular cell heterogeneity: endothelium, smooth muscle, and fibroblasts. Proc Am Thorac Soc 5: 783-791, 2008.
63. Stevens TC, Ochoa CD, Morrow KA, Robson MJ, Prasain N, Zhou C, Alvarez DF, Frank DW, Balczon R, Stevens T. The Pseudomonas aeruginosa exoenzyme Y impairs endothelial cell proliferation and vascular repair following lung injury. Am J Physiol Lung Cell Mol Physiol 306: L915-L924, 2014.
64. Su JH, Deng G, Cotman CW. Transneuronal degeneration in the spread of Alzheimer's disease pathology: immunohistochemical evidence for the transmission of tau hyperphosphorylation. Neurobiol Dis 4: 365-375, 1997.
65. Tartaglia MC, Hazrati LN, Davis KD, Green RE, Wennberg R, Mikulis D, Ezerins LJ, Keightley M, Tator C. Chronic traumatic encephalopathy and other neurodegenerative proteinopathies. Front Hum Neurosci 8: 30, 2014.
66. Thurston VC, Zinkowski RP, Binder LI. Tau as a nucleolar protein in human nonneural cells in vitro and in vivo. Chromosoma 105: 20-30, 1996.
67. Vallee RB, Collins CA. Purification of microtubules and microtubuleassociated proteins from sea urchin eggs and cultured mammalian cells using taxol and use of exogenous taxol-stabilized brain microtubules for purifying microtubule-associated proteins. Methods Enzymol 134: 116- 127, 1986.
68. Ward SM, Himmelstein DS, Lancia JK, Fu Y, Patterson KR, Binder LI. TOC1: characterization of a selective oligomeric tau antibody. J Alzheimers Dis 37: 593-602, 2013.
69. Ward SM, Himmelstein DS, Ren Y, Fu Y, Yu XW, Roberts K, Binder LI, Sahara N. TOC1: a valuable tool in assessing disease progression in the rTg4510 mouse model of tauopathy. Neurobiol Dis 67C: 37-48, 2014.
70. Wilson DM, Binder LI. Free fatty acids stimulate the polymerization of tau and amyloid-β peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease. Am J Pathol 150: 2181-2195, 1997.
71. Wong-Beringer A, Wiener-Kronish J, Lynch S, Flanagan J. Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa. Clin Microbiol Infect 14: 330-336, 2008.
72. Yahr TL, Vallis AJ, Hancock MK, Barbieri JT, Frank DW. ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system. Proc Natl Acad Sci USA 95: 13899-13904, 1998.